935 related articles for article (PubMed ID: 21252259)
1. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Sandler NG; Wand H; Roque A; Law M; Nason MC; Nixon DE; Pedersen C; Ruxrungtham K; Lewin SR; Emery S; Neaton JD; Brenchley JM; Deeks SG; Sereti I; Douek DC;
J Infect Dis; 2011 Mar; 203(6):780-90. PubMed ID: 21252259
[TBL] [Abstract][Full Text] [Related]
2. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.
Chevalier MF; Petitjean G; Dunyach-Rémy C; Didier C; Girard PM; Manea ME; Campa P; Meyer L; Rouzioux C; Lavigne JP; Barré-Sinoussi F; Scott-Algara D; Weiss L
PLoS Pathog; 2013; 9(6):e1003453. PubMed ID: 23818854
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals.
Negi N; Singh R; Sharma A; Das BK; Vajpayee M
Microb Pathog; 2017 Oct; 111():331-337. PubMed ID: 28801271
[TBL] [Abstract][Full Text] [Related]
4. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
5. Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV.
Monnig MA; Kahler CW; Cioe PA; Tucker L; Monti PM; Mayer KH; Ramratnam B
AIDS Care; 2016 Nov; 28(11):1434-40. PubMed ID: 27242060
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.
Kelesidis T; Kendall MA; Yang OO; Hodis HN; Currier JS
J Infect Dis; 2012 Nov; 206(10):1558-67. PubMed ID: 23066162
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of disease severity in patients with visceral leishmaniasis co-infected with HIV.
Ferreira GR; Santos-Oliveira JR; Silva-Freitas ML; Honda M; Costa DL; Da-Cruz AM; Costa CHN
Cytokine; 2022 Jan; 149():155747. PubMed ID: 34715475
[TBL] [Abstract][Full Text] [Related]
9. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
[TBL] [Abstract][Full Text] [Related]
10. Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.
Michelini Z; Baroncelli S; Fantauzzi A; Pasquale C; Galluzzo CM; Sanchez M; Gatto M; Amici R; Franco M; d'Ettorre G; Fimiani C; Mezzaroma I; Vullo V; Merli M; Palmisano L
HIV Clin Trials; 2016 Mar; 17(2):49-54. PubMed ID: 26739837
[TBL] [Abstract][Full Text] [Related]
11. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.
Sandler NG; Koh C; Roque A; Eccleston JL; Siegel RB; Demino M; Kleiner DE; Deeks SG; Liang TJ; Heller T; Douek DC
Gastroenterology; 2011 Oct; 141(4):1220-30, 1230.e1-3. PubMed ID: 21726511
[TBL] [Abstract][Full Text] [Related]
12. Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers.
Romero-Sánchez M; González-Serna A; Pacheco YM; Ferrando-Martínez S; Machmach K; García-García M; Alvarez-Ríos AI; Vidal F; Leal M; Ruiz-Mateos E
J Infect; 2012 Nov; 65(5):431-8. PubMed ID: 22728172
[TBL] [Abstract][Full Text] [Related]
13. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
French AL; Evans CT; Agniel DM; Cohen MH; Peters M; Landay AL; Desai SN
J Infect Dis; 2013 Aug; 208(4):679-89. PubMed ID: 23687224
[TBL] [Abstract][Full Text] [Related]
14. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
Papasavvas E; Pistilli M; Reynolds G; Bucki R; Azzoni L; Chehimi J; Janmey PA; DiNubile MJ; Ondercin J; Kostman JR; Mounzer KC; Montaner LJ
AIDS; 2009 Jan; 23(3):369-75. PubMed ID: 19114856
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
[TBL] [Abstract][Full Text] [Related]
16. Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
So-Armah KA; Tate JP; Chang CH; Butt AA; Gerschenson M; Gibert CL; Leaf D; Rimland D; Rodriguez-Barradas MC; Budoff MJ; Samet JH; Kuller LH; Deeks SG; Crothers K; Tracy RP; Crane HM; Sajadi MM; Tindle HA; Justice AC; Freiberg MS;
J Acquir Immune Defic Syndr; 2016 Jun; 72(2):206-213. PubMed ID: 27824677
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants.
Prendergast AJ; Chasekwa B; Rukobo S; Govha M; Mutasa K; Ntozini R; Humphrey JH
J Infect Dis; 2017 Sep; 216(6):651-661. PubMed ID: 28934432
[TBL] [Abstract][Full Text] [Related]
18. Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 Counts.
Affi R; Gabillard D; Dunyach-Remy C; Ntakpe JB; Moh R; Badje A; Kouame GM; Karcher S; Le Carrou J; Danel C; Chevalier MF; Rouzioux C; Eholie SP; Lavigne JP; Inwoley A; Anglaret X; Weiss L
J Acquir Immune Defic Syndr; 2021 Jan; 86(1):138-145. PubMed ID: 33074857
[TBL] [Abstract][Full Text] [Related]
19. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
[TBL] [Abstract][Full Text] [Related]
20. Markers of microbial translocation during pregnancy: differences among HIV+ women of African and European provenance.
Baroncelli S; Galluzzo CM; Molinari A; Pirillo MF; Cavalli A; Negri E; Floridia M; Degli Antoni A
J Infect Dev Ctries; 2020 Feb; 14(2):184-190. PubMed ID: 32146453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]